Highlights

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib Read more
Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition Read more
Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH’s Blood Read more
Read more news

Updates

Upcoming Events

View our financial calendar and what conferences, meetings, and congresses we will visit in 2022 on our upcoming events page.

Read more
FY 2022 presentation

Pharming announced its financial results for 2022 and held a presentation for analysts on Thursday, March 16, 2022. To download the presentation slides, please follow the link below.

Read more

Career opportunities

Our innovative technology and processes are aimed at purification and formulation of recombinant products. We are continuously looking for highly talented and motivated individuals to join our team.

Please take a look at our vacancies or send us an open application. We look forward to receiving your CV and motivation letter.

Career opportunities
woman in lab